IMM 1.69% 30.0¢ immutep limited

good for us bad for us pharmas, page-3

  1. 1,616 Posts.
    Spot on abdm, biotech is the next revenue stream in the medical space now that the old streams are drying up.

    THE BIOTECH BOOM IS INEVITABLE.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.